Abstract:Editor Langerhans cell sarcoma (LCS) is a rare disease. We report a case of LCS with cutaneous and breast involvement and an aggressive clinical course. To the best of our knowledge, no cases of LCS with breast involvement have been reported. An 81-year-old female consulted us about an asymptomatic periareolar lesion that had been present in the left breast for the last 2 months, with no evidence of weight loss or systemic symptoms. Personal antecedents were remarkable for a gradually enlarged cutaneous nodule on lower back, that had been extirpated by a private dermatologist 7 months before and was informed as “cutaneous lymphoma” in the pathological report. Physical examination revealed an erythematous, infiltrated plaque in left periareolar area, and a scar revealing the surgery that had been previously practiced in the back (Fig. 1a). No adenopathies or megalies were palpated. A skin biopsy of the lesion on the left breast demonstrated a diffuse dermal infiltration of atypical pleomorphic cells with numerous mitoses (Fig. 2a,b). The tumour cells expressed CD1a, CD4, S-100 protein and Langerin, suggesting a Langerhans cells (LC) phenotype (Fig. 2c). The ultrastructural study confirmed these findings, showing the cytoplasmic structures that are characteristic of the Birbeck granules in the infiltrate cells (Fig. 2d). Based on the histological and ultrastructural findings a diagnosis of LCS was made. In addition, we had the opportunity to review the biopsy of the previously excised skin lesion on the back that shared similar pathological findings. Mammography and echography showed diffuse trabecular thickening and axilar adenopathies. A body CT scan disclosed mammary involvement with asymmetry and volumetric augmentation (Fig. 2e). Fine needle aspiration biopsy of left mammary gland and adenopathies showed features compatible with infiltration by LCS. Peripheral blood smear did not reveal the presence of circulant malignant cells. Bone marrow aspirate examination was not considered. According to a diagnosis of cutaneous and mammary LCS with nodal metastasis the patient was treated with chemotherapy (Vinblastine, Dexamethasone and Cyclophosphamide) and adjuvant radiotherapy, but the disease progressed with extensive cutaneous, breast and nodal involvement until the death of the patient 9 months after the diagnosis (Fig. 1b). Langerhans cell sarcoma is a neoplastic disease characterized by a proliferation of LC with markedly malignant cytological features. Suggested criteria for the diagnosis of LCS are: (i) proliferating typical Birbeck granule-containing cells, and (ii) malignant cytological features like atypia and multiple mitotic figures. Langerhans cell sarcoma is considered a malignant aggressive neoplasm with poor prognosis. About 50 cases have been reported to date. Skin and lymph nodes are the most frequent sites of involvement, including some cases of cutaneous involvement of skin breast, but with no true infiltration of the breast. In contrast, our case showed true intramammary infiltration confirmed by fine needle aspiration biopsy. We think that this is the first case of LCS reported with breast involvement at the time of diagnosis. The breast involvement in this case could represent a metastatic event from the previously removed cutaneous lesion. LCS (a) (b)

Cutaneous and breast Langerhans cell sarcoma

Effects of Crystallization Temperature of Poly(vinylidene Fluoride) on Crystal Modification and Phase Transition of Poly(butylene Adipate) in Their Blends: a Novel Approach for Polymorphic Control.

Evaluation of amorphous solid dispersion properties using thermal analysis techniques

Experimental methods in chemical engineering: Thermogravimetric analysis—TGA

Cardiac transplantation in Hawai'i: a summary of the first 21 years.

Study on the Stability of Ion-Exchange Resin Catalysts: I. Tga As A Rapid Evaluating Method

Long-Term Stability of New Co-Amorphous Drug Binary Systems: Study of Glass Transitions as a Function of Composition and Shelf Time

Assessment of Thermal Transitions by Dynamic Mechanical Analysis (DMA) Using a Novel Disposable Powder Holder

3-D projection installations—three design strategies for a new medium

Long-Term Physical (In)Stability of Spray-Dried Amorphous Drugs: Relationship with Glass-Forming Ability and Physicochemical Properties

Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques

The Effect of Cooling on the Degree of Crystallinity, Solid-State Properties, and Dissolution Rate of Multi-Component Hot-Melt Extruded Solid Dispersions

Applications of Thermal Analysis and Coupled Techniques in Pharmaceutical Industry

Crystallization Tendency of Pharmaceutical Glasses: Relevance to Compound Properties, Impact of Formulation Process, and Implications for Design of Amorphous Solid Dispersions

[Quality control and optimization of therapeutic activity with the use of thermoanalytic methods]

Is a distinctive single Tg a reliable indicator for the homogeneity of amorphous solid dispersion?

Impact of Hot-Melt Extrusion on Glibenclamide's Physical and Chemical States and Dissolution Behavior: Case Studies with Three Polymer Blend Matrices

Advancing Thermal Stability Analysis of Haloperidol: Integrative Approaches and Optimization Strategies for Enhanced Pharmaceutical Formulations

Simulation and Experimental Study of the Isothermal Thermogravimetric Analysis and the Apparent Alterations of the Thermal Stability of Composite Polymers

Thermal Characterization of Crosslinked Polymeric Microspheres Bearing Thiol Groups Studied by TG/FTIR/DSC under Non-Oxidative Conditions

Stability of Dexamethasone during Hot-Melt Extrusion of Filaments based on Eudragit® RS, Ethyl Cellulose and Polyethylene Oxide